The UCI Breast Cancer Program hosts a booth at the Susan G. Komen Race for the Cure in Orange County
Mechanoresponsive cell system (MRCS) can selectively identify and treat cancer metastases by targeting the specific biophysical cues in the tumor niche.
Congrats to Ryan on a new chapter, and Bon voyage to our spectacular lab manager Anh! We will miss you and best of luck in medical school.
Undergrad researchers from our lab present posters on their research at the annual UCI Undergraduate Research Opportunities Program (UROP) symposium
Susan G. Komen Los Angeles hosts this annual Community Education conference for patients and families with Metastatic Breast Cancer. Local physicians, scientists, nutritionists, and wellness experts give lectures. Click ‘learn more’ to see the FB feed and Dr. Lawson’s presentation, which starts at 1:54.00
The Symposium was held in collaboration with Susan G. Komen, Orange County, and titled ‘Metastasis Research, Treatment, and Prevention Advances: From Bench to Bedside’ The goal was to present a summary of existing treatment options and ongoing research efforts in metastasis, for local patients, families, and patient advocates.
The Lawson lab is interested in understanding the cellular and molecular mechanisms underlying the metastatic spread of cancer cells to peripheral tissues. We take a systems-level approach, using cutting edge single-cell technologies to understand how the interplay between intracellular signals within the cancer cells, and extracellular stimuli from cells in the microenvironment influence the metastatic potential of individual cancer cells. We believe that new insights into the metastatic process will lead to new drugs to prevent and treat metastatic disease.
140 Sprague Hall
Chao Family Comprehensive Cancer Center
The University of California, at Irvine